A modified and unifying neurogenic hypothesis can explain the natural history of chronic Chagas heart disease

International Journal of Cardiology

Volumn 96, Issue 2, 2004, Pages 191-195

  Dávila, Diego F ^a   Donis, Jose H ^a   Torres, Argenis ^a   Ferrer, Jose A ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

Author keywords

Cardiac remodeling; Chagas; Neurohormonal activation; Trypanosoma cruzi

Indexed keywords

HORMONE ANTAGONIST; NEUROHORMONE;

ADRENERGIC SYSTEM; AUTOIMMUNITY; CARDIAC ANXIETY; CHAGAS DISEASE; ELECTROCARDIOGRAM; HEART VENTRICLE REMODELING; HUMAN; HYPOTHESIS; MORPHOLOGY; PARASITE; PARASYMPATHETIC INNERVATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 3242813813     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2003.06.015     Document Type: Article

References (66)

1. Chagas C. Nova entidad morbida do homem: resumo general dos estudos etiológicos e clinicos. Mem. Inst. Oswaldo Cruz. 3:1911;219-230
2. Maguire J.H., Hoff R., Sherlock I., et al. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation. 75:1987;1140-1145
3. Carrasco H.A., Parada H., Guerrero L., Duque M., Durán D., Molina C. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease. Int. J. Cardiol. 43:1994;27-38
4. Ianni B.M., Arteaga E., de Carvalho Frim C., Pereira C., Barreto A.C., Mady C. Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form. Arq. Bras. Cardiol. 77:2001;59-62
5. Factor S.M., Cho S., Wittner M. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am. J. Trop. Med. Hyg. 34:1985;246-253
6. Factor S.M., Sonnenblick E.H. The pathogenesis of clinical and experimental congestive cardiomyopathies: recent concepts. Prog. Cardiovasc. Dis. 27:1985;395-420
7. Morris S.A., Tanowitz H.B., Wittner M., Bilezikian J.P. Pathophysiological insights into the cardiomoypathy of Chagas' disease. Circulation. 82:1990;1900-1909
8. Rossi M.A., Bestetti R.B. The challenge of chagasic cardiomyopathy. The pathologic roles of autonomic abnormalities, autoimmune mechanisms and microvascular changes and therapeutic implications. Cardiology. 86:1995;1-7
9. Bestetti R.B., Rossi M.A. A rationale approach for mortality risk stratification in Chagas' heart disease. Int. J. Cardiol. 58:1997;199-209
10. Kierszenbaum F. Chagas' disease and the autoimmunity hypothesis. Clin. Microbiol. Rev. 12:1999;210-223
11. Tafuri W.L. Immunopathology of Chagas disease - a historical overview. Mem. Inst. Oswaldo Cruz. 94(S1):1999;247-248
12. Engman D.M., Leon J.S. Pathogenesis of Chagas heart disease: role of autoimmunity. Acta. Trop. 81:2002;123-132
13. Tarleton R.L. Parasite persistence in the aetiology of Chagas disease. Int. J. Parasitol. 31:2001;550-554
14. Leon J.S., Engman D.M. Autoimmunity in Chagas heart disease. Int. J. Parasitol. 31:2001;555-560
15. Jones E.M., Colley D.G., Tostes S., Lopes E.R., Vnencak-Jones C.L., McCurley T.L. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am. J. Trop. Med. Hyg. 48:1993;348-357
16. Añez N., Carrasco H., Parada H., et al. Myocardial parasite persistence in chronic chagasic patients. Am. J. Trop. Med. Hyg. 60:1999;726-732
17. Monteon-Padilla V., Hernandez-Becerril N., Ballinas-Verdugo M.A., Aranda-Fraustro A., Reyes P.A. Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients. Arch. Med. Res. 32:2001;39-43
18. Higuchi M.L., de Brito T., Martins Reis M., et al. Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: light microscopy and immunohistochemical findings. Cardiovasc. Pathol. 2:1993;101-106
19. Pereira J.B., Wilcox H.P., Coura J.R. The evolution of chronic chagasic cardiopathy: I. The influence of parasitemia. Rev. Soc. Bras. Med. Trop. 25:1992;101-108
20. Baig M.K., Salomone O., Cafioro A.L., et al. Human chagasic disease is not associated with an antiheart humoral response. Am. J. Cardiol. 79:1997;1135-1137
21. Rosenbaum M.B., Chiale P.A., Schejtman D., Levin M., Elizari M.V. Antibodies to beta-adrenergic receptors disclosing agonist-like properties in idiopathic dilated cardiomyopathy and Chagas' heart disease. J. Cardiovasc. Electrophysiol. 5:1994;367-375
22. de Oliveira S.F., Pedrosa R.C., Nascimento J.H., Campos de Carvalho A.C., Masuda M.O. Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation. 96:1997;2031-2037
23. Chiale P.A., Ferrari I., Mahler E., et al. Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation. 103:2001;1765-1771
24. Liu H.R., Zhao R.R., Jiao X.Y., Wang Y.Y., Fu M. Relationship of myocardial remodeling to the genesis of serum antibodies to cardiac beta (1)-adrenoceptors and muscarinic type 2 acetylcholine receptors in rats. J. Am. Coll. Cardiol. 39:2002;1866-1873
25. Urbina J.A. Chemotherapy of Chagas' disease: the how and the why. J. Mol. Med. 77:1999;332-338
26. Acquatella H., Davalos V., Catalioti F., Rodriguez L., Gomez J.R., Morales E. Early interruption of a prospective, doubled blind and placebo-controlled clinical study of Enalapril in Chagas' heart disease (Abst. no. 74). XIV InterAmerican Congress of Cardiology, Florida, USA. 1992;23
27. Dávila D.F., Inglessis G., Mazzei de Davila C.A. Chagas' disease and the autonomic nervous system. Int. J. Cardiol. 66:1998;123-127
28. Davila D.F., Angel F., Donis J.H., Arata de Bellabarba G. Effects of metoprolol in chagasic patients with severe congestive heart failure. Int. J. Cardiol. 85:2002;255-260
29. Szanjnbok F.E., Barreto A.C., Mady C., et al. Beneficial effects of enalapril on the diastolic ventricular function in Chagas myocardiopathy. Arq. Bras. Cardiol. 60:1993;273-278
30. Acquatella H., Catalioti F., Gomez-Mancebo J.R., Davalos V., Villalobos L. Longterm control of Chagas' disease in Venezuela: effects on serologic findings, electrocardiographic abnormalities and clinical outcome. Circulation. 76:1987;556-562
31. Bestetti R.B., Dalbo C.M.R., Freitas O.C., Teno L.A., Castilho O.T., Oliveira J.S. Noninvasive predictors of mortality for patients with Chagas' heart disease: a multivariate stepwise logistic regression study. Cardiology. 84:1994;261-267
32. Eichorn E.J., Bristow M.R. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation. 94:1996;2285-2296
33. Kitamura S., Kay J.H., Krohn B.G., Madison O., Dunne E.F. Geometric and functional abnormalities of the left ventricle with a chronic localized noncontractile area. Am. J. Cardiol. 31:1973;701-707
34. Douglas P.S., Morrow R., Ioli A., Reicheck N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 13:1989;311-315
35. Pfeffer M.A., Pfeffer J.M., Steinberg C., Finn P. Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation. 72:1985;406-412
36. Eckberg D.L., Drabinsky M., Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N. Eng. J. Med. 285:1971;877-883
37. Azevedo E.R., Parker J.D. Parasympathetic control of cardiac sympathetic activity. Normal ventricular function versus congestive heart failure. Circulation. 100:1999;274-279
38. Mann D.L. Mechanisms and models in heart failure. A combinatorial approach. Circulation. 100:1999;999-1008
39. Parada H., Carrasco H.A., Añez N., Fuenmayor C., Inglessis I. Cardiac involvement is a constant finding in acute Chagas' disease: a clinical, parasitological and histopathological study. Int. J. Cardiol. 60:1997;49-54
40. Pinto A.Y., Harada G.S., Valente V.D., et al. Cardiac attacks in patients with acute Chagas' disease in a family micro-outbreak episode in Abaetetuba, Brazilian Amazon. Rev. Soc. Bras. Med. Trop. 34:2001;413-419
41. Acquatella H. Chagas' disease. Braunwald E. Atlas of heart diseases. Philadelphia: current medicine (cardiomyopathies, myocarditis and pericardial disease). vol. 2:1995;8.1-8.18
42. Bestetti R.B., Ramos C.P., Figueredo-Silva J., Sales-Neto V.N., Oliveira J.S. Ability of the electrocardiogram to detect myocardial lesions in isoproterenol induced rat cardiomyopathy. Cardiovasc. Res. 21:1987;916-921
43. Rossi M.A., Ribeiro-dos Santos R., Goncalves S. Pathogenesis of the apical aneurysm in experimental Trypanosoma cruzi cardiomyopathy in BALB/c mice. Trans. R. Soc. Trop. Med. Hyg. 80:1986;990-991
44. Carrasco H.A., Barboza J.S., Inglessis G., Fuenmayor A., Molina C. Left ventricular cineangiography in Chagas' disease: detection of early myocardial damage. Am. Heart J. 104:1982;595-602
45. Ribeiro A.L., Rocha M.O., Barros M.V., Rodrigues A.R., Machado F.S. A Narrow QRS does not predict a normal left ventricular function in Chagas' disease pacing. Clin. Electrophysiol. 23(Pt 2):2000;2014-2017
46. Davila D.F., Donis J.H., Torres A., Gotteberg C.F., Bellabarba G., Holzaker G., et al. Apìcal left ventricular aneurysm and cardiac parasympathetic innervation in Chagas' heart disease. Med. Hypotheses. 42:1994;53-56
47. Frustaci A., Maseri A. Localized left ventricular aneurysms with normal global function caused by myocarditis. Am. J. Cardiol. 70:1992;1221-1224
48. Bradfield J.W., Beck G., Vecht R.J. Left ventricular apical thin point. Br. Heart J. 39:1977;806-810
49. Hammermeister K.E., Gibbson D.G., Hughes D. Regional variation of the timing and extent of left ventricular wall motion in normal subjects. Br. Heart J. 56:1986;226-230
50. Mori H., Ishikawa S., Kojima S., et al. Increased responsiveness of left ventricular apical myocardium to adrenergic stimuli. Cardiovasc. Res. 27:1993;192-198
51. Kono T., Morita H., Kuroiwa T., Onaka H., Takatsuka H., Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J. Am. Coll. Cardiol. 24:1994;636-640
52. Leon J.S., Wang K., Engman D.M. Captopril ameliorates myocarditis in acute experimental Chagas disease. Circulation. 107:2003;2264-2269
53. Godsel L.M., Leon J.S., Engman D.M. Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in experimental myocarditis. Curr. Pharm. Des. 9:2003;723-735
54. Bestetti R.B., Sales-Neto V.N., Pinto L.Z., Soares E.G., Muccillo G., Oliveira J.S. Effects of long term metoprolol administration on the electrocardiogram of rats infected with T. cruzi. Cardiovasc. Res. 24:1990;521-527
55. Koberle F. Cardiopathia parasympathicopriva. Munch. Med. Wochenschr. 101:1959;1308-1310
56. Odreman R.O., Davila D.F., Donis J.H., Torres A., Ferrer A., Inglessis I. Valsalva maneuver in chagasic patients with documented past medical history of acute chagasic myocarditis. Int. J. Cardiol. 93:2004;163-167
57. Bestetti R.B., Coutinho-Neto J., Staibano L., Pinto L.Z., Muccillo G., Oliveira J.S. Peripheral and coronary sinus catecholamine levels in patients with severe congestive heart failure due to Chagas' disease. Cardiology. 86:1995;202-206
58. Ribeiro A.L.P., Dos Reis A.M., Barros M.V., et al. Brain natriuretic peptide and left ventricular dysfunction in Chagas disease. Lancet. 360:2002;461-462
59. Salomone O.A., Caeiro T.F., Madoery R.J., et al. High plasma immunoreactive endothelin levels in patients with Chagas' cardiomyopathy. Am. J. Cardiol. 87:2001;1217-1220
60. Dávila D.F., Donis J.H., Bellabarba G., Torres A., Casado J., Mazzei de Dávila C. Cardiac afferents and neurohormonal activation in congestive heart failure. Med. Hypotheses. 54:2000;242-253
61. Davila D.F., Rossell O., Arata de Bellabarba G. Pathogenesis of chronic Chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation. Int. J. Parasitol. 32:2002;107-109
62. de Almeida-Filho O.C., Maciel B.C., Schmidt A., Pazin-Filho A., Marin-Neto A. Minor segmental dyssinergy reflects extensive myocardial damage and global left ventricular dysfunction in chronic Chagas disease. J. Am. Soc. Echocardiogr. 15:2002;606-610
63. Rodríguez-Salas L.A., Klein E., Acquatella H., Catalioti F., Dávalos V., Gomez-Mancebo J.R., et al. Echocardiographic predictors of mortality in chronic Chagas' disease. Echocardiography. 15:1998;271-277
64. Patel A.R., Lima C., Parro A., Arsenault M., Bañan M.A., Pandian N.G. Echocardiographic analysis of regional and global left ventricular shape in chagas cardiomyopathy. Am. J. Cardiol. 82:1998;197-202
65. Camara E.J.N. Left ventricular segmental wall motion abnormalities in dilated and non-dilated Chagas' cardiopathy. Arq. Bras. Cardiol. 60:1993;151-155
66. Jahns R., Boivin V., Siegmund C., Inselmann G., Lohse M.J., Boege F. Autoantibodies activating human B1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure. Circulation. 99:1999;649-654